The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's Disease in the Northwest of Iran
- PMID: 34178809
- PMCID: PMC8214605
- DOI: 10.18502/ijph.v50i3.5621
The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's Disease in the Northwest of Iran
Abstract
Background: Parkinson's disease (PD) is a prevalent neurodegenerative disorder. Oxidative stress is a main modulator in the advancement of PD. This investigation aimed to evaluate the relations between serum trace elements, vitamin C, ferritin, transferrin, Nitrite Oxide (NOx) and Peroxynitrite (PrN) concentrations and clinical parameters in patients with PD.
Methods: Serum concentrations of variables were measured in 75 PD patients and 75 healthy subjects from Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran between Feb 2016 and Sep 2018. Receiver Operating Characteristic (ROC) analysis was performed to examine incremental diagnostic value of vitamin C, NOx, and PrN in the study groups.
Results: Mean serum NOx (35.81±5.16 vs. 11.27±3.59 mol/L, P<0.001) and PrN (15.78±4.23 vs. 9.62±4.57 mol/L, P= 0.004) were markedly higher in patient group versus healthy individuals. Significant differences were also observed in the serum levels of vitamin C (P<0.001), copper (Cu) (P<0.001), Iron (Fe) (P=0.003), and Zinc (Zn) (P<0.001) between patients with PD and healthy subjects. Nevertheless, the serum levels of Se (P=0.515), ferritin (P=0.103), and transferrin (P=0.372) were not statistically significant between the study groups. ROC analysis has revealed a diagnostic ability of serum vitamin C levels for PD with an area under ROC curve of ≥0.7 (P<0.05) and relatively high sensitivity and specificity.
Conclusion: Serum levels of NOx and PrN are significantly higher in patients with PD. In additions, serum vitamin C levels have a diagnostic value as a biomarker. Further studies are required with larger sample size to provide more detailed information about the cognitive profile of participants and the outcome measures.
Keywords: Ferritin; Nitric oxide; Oxidative stress; Parkinson diseases; Trace elements.
Copyright © 2021 Barmaki et al. Published by Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of interest The authors declare that there is no conflict of interests.
Figures




Similar articles
-
Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease.Clin Biochem. 2017 Dec;50(18):1087-1092. doi: 10.1016/j.clinbiochem.2017.09.014. Epub 2017 Sep 20. Clin Biochem. 2017. PMID: 28941592
-
Dysregulation of body antioxidant content is related to initiation and progression of Parkinson's disease.Neurosci Lett. 2020 Sep 25;736:135297. doi: 10.1016/j.neulet.2020.135297. Epub 2020 Aug 7. Neurosci Lett. 2020. PMID: 32771603
-
Evidence-Based Discriminant Analysis: A New Insight into Iron Profile for the Diagnosis of Parkinson's Disease.Ann Indian Acad Neurol. 2021 Mar-Apr;24(2):234-238. doi: 10.4103/aian.AIAN_419_20. Epub 2021 Apr 6. Ann Indian Acad Neurol. 2021. PMID: 34220068 Free PMC article.
-
Metals, oxidative stress and neurodegenerative disorders.Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Epub 2010 Aug 22. Mol Cell Biochem. 2010. PMID: 20730621 Review.
-
Status and potential diagnostic roles of essential trace elements in Kashin- Beck disease patients.J Trace Elem Med Biol. 2022 Jan;69:126880. doi: 10.1016/j.jtemb.2021.126880. Epub 2021 Oct 25. J Trace Elem Med Biol. 2022. PMID: 34717166 Review.
Cited by
-
Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials.Neural Regen Res. 2025 Aug 1;20(8):2245-2263. doi: 10.4103/NRR.NRR-D-24-00025. Epub 2024 Jul 29. Neural Regen Res. 2025. PMID: 39104166 Free PMC article.
-
Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.Biometals. 2024 Feb;37(1):3-22. doi: 10.1007/s10534-023-00530-9. Epub 2023 Aug 18. Biometals. 2024. PMID: 37594582
-
Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson's Disease.Int J Mol Sci. 2022 Mar 26;23(7):3625. doi: 10.3390/ijms23073625. Int J Mol Sci. 2022. PMID: 35408992 Free PMC article. Review.
-
Could Vitamins Have a Positive Impact on the Treatment of Parkinson's Disease?Brain Sci. 2023 Feb 6;13(2):272. doi: 10.3390/brainsci13020272. Brain Sci. 2023. PMID: 36831815 Free PMC article. Review.
-
Pesticide Exposure and Its Association with Parkinson's Disease: A Case-Control Analysis.Cell Mol Neurobiol. 2024 Nov 1;44(1):73. doi: 10.1007/s10571-024-01501-5. Cell Mol Neurobiol. 2024. PMID: 39485576 Free PMC article.
References
-
- Hemmati-Dinarvand M, Taher-Aghdam A-A, Mota A, Vahed SZ, Samadi N. (2017). Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson’s disease. Clin Biochem, 50(18):1087–1092. - PubMed
-
- Kouti L, Noroozian M, Akhondzadeh S, et al. (2013). Nitric oxide and peroxynitrite serum levels in Parkinson’s disease: correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci, 17(7):964–70. - PubMed
-
- Wang N, Jin X, Guo D, Tong G, Zhu X. (2017). Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson Disease. Biomacromolecules, 18(2):461–474. - PubMed
-
- Prasad S, Gupta SC, Tyagi AK. (2017). Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett, 387:95–105. - PubMed
LinkOut - more resources
Full Text Sources